While the benefits of semaglutide in treating obesity and type 2 diabetes are well-established, it is important to consider the effects that may occur when treatment is discontinued
These studies, which informed regulatory approval by the MHRA and EMA, have consistently demonstrated significant improvements in glycaemic control and metabolic parameters
Human studies, although limited, also suggest potential cognitive benefits
However, processing and preserving foods (besides freezing) can cause foods to lose their glutathione. Interestingly, research suggests that a lack of protein in general can lower glutathione levels, at least in humans
The data also revealed demographic trends: individuals qualifying under weight management were younger (average age 50.1 years) compared to those qualifying under diabetes (59.6 years) or secondary CVD prevention (66.2 years)